Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin
- 1 August 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (8) , 2163-2169
- https://doi.org/10.1002/eji.1830250807
Abstract
During ontogeny, the skin is progressively populated by major histocompatibility complex class II-negative dendritic cell (DC) precursors that then mature into efficient antigen-presenting cells (APC). To characterize these DC progenitors better, we generated myeloid cell lines from fetal mouse skin by infecting cell suspensions with a retroviral vector carrying an envAKR-mycMH2 fusion gene. These cells, represented by the line FSDC, displayed a dendritic morphology and their proliferation in serum-free medium was promoted by granulocyte/macrophage colony-stimulating factor (GM-CSF), but not macrophage-CSF. FSDC expressed strong surface-membrane ATP/ADPase activity, intracellular staining for 2A1 antigen, and a surface phenotype consistent with a myeloid precursor: H-2d.b+, I-Ad.b+, CD54+, CD11b+, CD11c+, 2.4G2+, F4/80+, CD44+, 2F8+, ER-MP 12−, Sca-1+, Sca-2+, NLDC-145−, B7.2+, B7.1−, J11d−, B220−, Thy-1−, and CD3−. FSDC stimulated poorly allogeneic or syngeneic T cells in the primary mixed-leukocyte reaction, and markedly increased this function after treatment with GM-CSF, GM-CSF and interleukin (IL)-4 or interferon-γ (IFN-γ); in contrast, stem cell factor, IL-1α and tumor necrosis factor-α had no effect. Preculture with IFN-γ was required for presentation of haptens to primed T cells in vitro. However, FSDC, even after cytokine activation, were less potent APC than adult epidermal Langerhans cells in both of the above assays. Finally, FSDC derivatized with haptens and injected either intravenously or subcutaneously could efficiently induce contact sensitivity responses in naive syngeneic mice. The results indicate that fetal mouse skin is colonized by myeloid precursors possessing a macrophage/immature DC-like surface phenotype and priming capacity in vivo. These cells need further differentiation and activation signals (e.g. cytokines) to express their antigen presenting potential in vitro.Keywords
This publication has 35 references indexed in Scilit:
- B7‐1 expression of Langerhans cells is up‐regulated by proinflammatory cytokines, and is down‐regulated by interferon‐γ or by interleukin‐10European Journal of Immunology, 1995
- Distinction of Class II MHC+ Langerhans Cell-Like Interstitial Dendritic Antigen-Presenting Cells in Murine Dermis from Dermal MacrophagesJournal of Investigative Dermatology, 1994
- Modulation of cytokine expression in mouse dendritic cell clonesEuropean Journal of Immunology, 1994
- Understanding the dendritic cell lineage through a study of cytokine receptors.The Journal of Experimental Medicine, 1994
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992
- GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsNature, 1992
- Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements.The Journal of Experimental Medicine, 1992
- Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.The Journal of Experimental Medicine, 1990
- Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigensEuropean Journal of Immunology, 1990
- Epidermal Langerhans cells are derived from cells originating in bone marrowNature, 1979